「and areductionin」の検索結果
110件：61～65件目を表示
もしかして
-
eveloped compound having the development code SJP-0008 was granted by the Ministry of Health, Labor and Welfare (HMLW) on June 19, 2024, as an orphan drug of the Central Retinal Artery Occlusion (CRAO...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708_0.pdf -
Business Activities | About Senju | SENJU Pharmaceutical
Based on a sense of mission to contribute to the health of the eyes of people around the world, and a development policy that puts top priority on safety, we have always taken a pioneering path in oph...
https://www.senju.co.jp/english/about/business/ -
eveloped compound having the development code SJP-0008 was granted by the Ministry of Health, Labor and Welfare (HMLW) on June 19, 2024, as an orphan drug of the Central Retinal Artery Occlusion (CRAO...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708.pdf -
t M22 IPL Model is indicated for improvement of symptoms of Dry Eye Disease due to MGD (Meibomian Gland Dysfunction ), and was previously approved by the Ministry of Health, Labor and Welfare in Japan...
https://www.senju.co.jp/system/files/content_news/2023-11/ENG__20231101_0.pdf -
Milestones in Our History | About Senju | SENJU Pharmaceutical
sales launched. May Company head office relocated to Kita-ku, Osaka 1972 March Company head office and Osaka branch are relocated to Hiranomachi, Higashi-ku, Osaka 1974 June Fukusaki Plant for manufa...
https://www.senju.co.jp/english/about/history.html